Pages that link to "Q56904178"
Jump to navigation
Jump to search
The following pages link to CTLA4 blockade maximizes antitumor T-cell activation by dendritic cells presenting idiotype protein or opsonized anti-CD20 antibody-coated lymphoma cells (Q56904178):
Displaying 15 items.
- Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma (Q26999011) (← links)
- An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy (Q31121276) (← links)
- Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402 (Q34173622) (← links)
- Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome (Q35211577) (← links)
- Clonal cytotoxic T cells in myeloma (Q35614630) (← links)
- Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant? (Q35819325) (← links)
- Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab (Q36219690) (← links)
- Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study (Q36281132) (← links)
- Update on vaccine development for renal cell cancer (Q36989720) (← links)
- Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma (Q37738497) (← links)
- Allogeneic stem cell transplantation in follicular lymphoma (Q37887151) (← links)
- B7-H4 expression in bladder urothelial carcinoma and immune escape mechanisms (Q38943258) (← links)
- Rituximab for the treatment of patients with chronic lymphocytic leukemia (Q41241909) (← links)
- Activation outcomes induced in naïve CD8 T-cells by macrophages primed via "phagocytic" and nonphagocytic pathways (Q41943210) (← links)
- Targeting cluster of differentiation 47 improves the efficacy of anti-cytotoxic T-lymphocyte associated protein 4 treatment via antigen presentation enhancement in pancreatic ductal adenocarcinoma (Q98778887) (← links)